Hearing Tracker·Financial report·Business & finance·7d agoGN Hearing Delivers 9% Organic Growth as Amplifon Carve-Out Moves ForwardGN Hearing's strong organic growth signals continued investment capacity in hearing aid R&D and distribution, while the Amplifon carve-out may reshape retail clinic ownership dynamics across the sector.
MedWatch·Financial report·Business & finance·8d agoAmplifon upgrades earnings guidance despite flat revenue – ready for GN mega-mergerThe Amplifon–GN Hearing integration is one of the largest consolidations in the audiology retail and manufacturing sectors, with potential downstream effects on product availability and clinic competition.＋Save
Hearing Tracker·Industry news·Business & finance·8w agoWill the Amplifon-GN Deal Redraw the U.S. Hearing Aid Map?Vertical integration of a dominant retail chain with a top-five manufacturer could constrain independent audiologists' access to ReSound/Jabra products and shift competitive power in the U.S. market.＋Save
Hearing Tracker·Industry news·Business & finance·8w agoAmplifon Strikes Deal to Buy GN Hearing in $2.64 B TransactionA combined Amplifon–GN Hearing entity would vertically integrate a top global retail chain with a major manufacturer, potentially reshaping brand distribution, pricing, and independent clinic access to GN products.＋Save
